Evidence map›Paper›PMID 37700029›Full record

ReviewNPJ digital medicine2023

Considerations for addressing bias in artificial intelligence for health equity.

Michael D Abràmoff, Michelle E Tarver, Nilsa Loyo-Berrios, Sylvia Trujillo, Danton Char, Ziad Obermeyer, Malvina B Eydelman, Foundational Principles of Ophthalmic Imaging and Algorithmic Interpretation Working Group of the Collaborative Community for Ophthalmic Imaging Foundation, Washington, D.C., William H Maisel

Abstract readReview
In one paragraph

Review in NPJ digital medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 140 papers.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Ethics of Autonomous AI Clinical Trials: Delphi Study.Journal of medical Internet research · 2026
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Artificial intelligence in pediatric myopia - a narrative review.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Michael D AbràmoffDepartments of Ophthalmology and Visual Sciences, and Electrical and Computer Engineering, University of Iowa, Iowa City, IA, USA. michael-abramoff@uiowa.edu.ORCID http://orcid.org/0000-0002-3490-0037
Michelle E TarverCenter for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD, USA.
Nilsa Loyo-BerriosCenter for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD, USA.
Sylvia TrujilloOCHIN, Portland, OR, USA.
Danton CharCenter for Biomedical Ethics, Stanford University School of Medicine, San Francisco, CA, USA.
Ziad ObermeyerSchool of Public Health, University of California, Berkeley, CA, USA.
Malvina B EydelmanCenter for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD, USA.
Foundational Principles of Ophthalmic Imaging and Algorithmic Interpretation Working Group of the Collaborative Community for Ophthalmic Imaging Foundation, Washington, D.C.
William H MaiselCenter for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Health equity is a primary goal of healthcare stakeholders: patients and their advocacy groups, clinicians, other providers and their professional societies, bioethicists, payors and value based care organizations, regulatory agencies, legislators, and creators of artificial intelligence/machine learning (AI/ML)-enabled medical devices. Lack of equitable access to diagnosis and treatment may be improved through new digital health technologies, especially AI/ML, but these may also exacerbate disparities, depending on how bias is addressed. We propose an expanded Total Product Lifecycle (TPLC) framework for healthcare AI/ML, describing the sources and impacts of undesirable bias in AI/ML systems in each phase, how these can be analyzed using appropriate metrics, and how they can be potentially mitigated. The goal of these "Considerations" is to educate stakeholders on how potential AI/ML bias may impact healthcare outcomes and how to identify and mitigate inequities; to initiate a discussion between stakeholders on these issues, in order to ensure health equity along the expanded AI/ML TPLC framework, and ultimately, better health outcomes for all.

Identifiers

PMID37700029
PMCPMC10497548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.